|
1
|
Zhang Y, Rumgay H, Li M, Cao S and Chen W:
Nasopharyngeal cancer incidence and mortality in 185 countries in
2020 and the projected burden in 2040: Population-based global
epidemiological profiling. JMIR Public Health Surveill.
9(e49968)2023.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Lin JC, Wang WY, Chen KY, Wei YH, Liang
WM, Jan JS and Jiang RS: Quantification of plasma Epstein-Barr
virus DNA in patients with advanced nasopharyngeal carcinoma. N
Engl J Med. 350:2461–2470. 2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cao C, Treechairusame T, Safavi AH, Wu Y,
Zhang Z, Shamseddine A, Yu Y, Riaz N, Gelblum DY, McBride SM, et
al: Intensity-modulated proton therapy vs intensity-modulated
radiotherapy in nasopharyngeal carcinoma: A case-control study.
Lancet Reg Health Am. 54(101352)2026.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Liu YC, Wang WY, Twu CW, Jiang RS, Liang
KL, Lin PJ, Lin JW and Lin JC: Comparison long-term outcome of
definitive radiotherapy plus different chemotherapy schedules in
patients with advanced nasopharyngeal carcinoma. Sci Rep.
8(470)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD,
Yang KY, Jin F, Shi M, Chen YP, Hu WH, et al: Final overall
survival analysis of gemcitabine and cisplatin induction
chemotherapy in nasopharyngeal carcinoma: A multicenter, randomized
phase III trial. J Clin Oncol. 40:2420–2425. 2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jin S, Li R, Chen MY, Yu C, Tang LQ, Liu
YM, Li JP, Liu YN, Luo YL, Zhao Y, et al: Single-cell
transcriptomic analysis defines the interplay between tumor cells,
viral infection, and the microenvironment in nasopharyngeal
carcinoma. Cell Res. 30:950–965. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gong L, Kwong DLW, Dai W, Wu P, Wang Y,
Lee AWM and Guan XY: The stromal and immune landscape of
nasopharyngeal carcinoma and its implications for precision
medicine targeting the tumor microenvironment. Front Oncol.
11(744889)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hsu HW, Wall NR, Hsueh CT, Kim S, Ferris
RL, Chen CS and Mirshahidi S: Combination antiangiogenic therapy
and radiation in head and neck cancers. Oral Oncol. 50:19–26.
2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Guo G, Wang Y, Zhou Y, Quan Q, Zhang Y,
Wang H, Zhang B and Xia L: Immune cell concentrations among the
primary tumor microenvironment in colorectal cancer patients
predicted by clinicopathologic characteristics and blood indexes. J
Immunother Cancer. 7(179)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhu Q, Pan QZ, Zhong AL, Hu H, Zhao JJ,
Tang Y, Hu WM, Li M, Weng DS, Chen MY, et al: Annexin A3
upregulates the infiltrated neutrophil-lymphocyte ratio to remodel
the immune microenvironment in hepatocellular carcinoma. Int
Immunopharmacol. 89(107139)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chen YP, Zhao BC, Chen C, Shen LJ, Gao J,
Mai ZY, Chen MK, Chen G, Yan F, Liu S and Xia YF: Pretreatment
platelet count improves the prognostic performance of the TNM
staging system and aids in planning therapeutic regimens for
nasopharyngeal carcinoma: A single-institutional study of 2,626
patients. Chin J Cancer. 34:137–146. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tecchio C, Scapini P, Pizzolo G and
Cassatella MA: On the cytokines produced by human neutrophils in
tumors. Semin Cancer Biol. 23:159–170. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mantovani A, Cassatella MA, Costantini C
and Jaillon S: Neutrophils in the activation and regulation of
innate and adaptive immunity. Nat Rev Immunol. 11:519–531.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Irawan C, Rachman A, Rahman P and Mansjoer
A: Role of pretreatment hemoglobin-to-platelet ratio in predicting
survival outcome of locally advanced nasopharyngeal carcinoma
patients. J Cancer Epidemiol. 2021(1103631)2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lin Z, Zhang X, Luo Y, Chen Y and Yuan Y:
The value of hemoglobin-to-red blood cell distribution width ratio
(Hb/RDW), neutrophil-to-lymphocyte ratio (NLR), and
platelet-to-lymphocyte ratio (PLR) for the diagnosis of
nasopharyngeal cancer. Medicine. 100(e26537)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Amin MB, Edge SB, Greene FL, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR
and Sullivan DC (eds.): AJCC Cancer Staging Manual. 8th edition.
Springer, New York, NY, 2017.
|
|
17
|
Cao SM, Yang Q, Guo L, Mai HQ, Mo HY, Cao
KJ, Qian CN, Zhao C, Xiang YQ, Zhang XP, et al: Neoadjuvant
chemotherapy followed by concurrent chemoradiotherapy versus
concurrent chemoradiotherapy alone in locoregionally advanced
nasopharyngeal carcinoma: A phase III multicentre randomised
controlled trial. Eur J Cancer. 75:14–23. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chen L, Hu CS, Chen XZ, Hu GQ, Cheng ZB,
Sun Y, Li WX, Chen YY, Xie FY, Liang SB, et al: Concurrent
chemoradiotherapy plus adjuvant chemotherapy versus concurrent
chemoradiotherapy alone in patients with locoregionally advanced
nasopharyngeal carcinoma: A phase 3 multicentre randomised
controlled trial. Lancet Oncol. 13:163–171. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS
and Wang WY: Phase III study of concurrent chemoradiotherapy versus
radiotherapy alone for advanced nasopharyngeal carcinoma: Positive
effect on overall and progression-free survival. J Clin Oncol.
21:631–637. 2003.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang YW, Ho SY, Lee SW, Chen CC, Litsu S,
Huang WT, Yang CC, Lin CH, Chen HY and Lin LC: Induction
chemotherapy improved long term outcomes in stage IV locoregional
advanced nasopharyngeal carcinoma. Int J Med Sci. 17:568–576.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Qing Y, Xiaomin O and Chaosu H: Prognostic
significance of platelet-to-lymphocyte ratio in patients with
nasopharyngeal carcinoma: A Meta-analysis. China Oncol. 29:576–582.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang J, Feng W, Ye Z, Wei Y, Li L and
Yang Y: Prognostic significance of platelet-to-lymphocyte ratio in
patients with nasopharyngeal carcinoma: A meta-analysis. Future
Oncol. 16:117–127. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lu A, Li H, Zheng Y, Tang M, Li J, Wu H,
Zhong W, Gao J, Ou N and Cai Y: Prognostic significance of
neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio, and
platelet to lymphocyte ratio in patients with nasopharyngeal
carcinoma. BioMed Res Int. 2017(3047802)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Pulito C, Cristaudo A, Porta CL, Zapperi
S, Blandino G, Morrone A and Strano S: Oral mucositis: The hidden
side of cancer therapy. J Exp Clin Cancer Res.
39(210)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lee KH, Seok EY, Kim EY, Yun JS, Park YL
and Park CH: Different prognostic values of individual hematologic
parameters in papillary thyroid cancer due to age-related changes
in immunity. Ann Surg Treat Res. 96:70–77. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Liu LT, Chen QY, Tang LQ, Guo SS, Guo L,
Mo HY, Chen MY, Zhao C, Guo X, Qian CN, et al: The prognostic value
of treatment-related lymphopenia in nasopharyngeal carcinoma
patients. Cancer Res Treat. 50:19–29. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Huang XX, Qin XL, Huang WM and Huang B:
The predictive value of hematological inflammatory markers for
severe oral mucositis in patients with nasopharyngeal carcinoma
during intensity-modulated radiation therapy: A retrospective
cohort study. Curr Probl Cancer. 51(101117)2024.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Adiwinata R, Livina A, Haroen H, Rotty L,
Harijanto PN, Nugroho A, Hendratta C, Lasut P and Kawengian C:
Adverse cutaneous drug reaction following granulocyte
colony-stimulating factor administration in nasopharynx cancer
patient with febrile neutropenia: A case report. Indonesian J
Cancer. 16:189–193. 2022.
|
|
29
|
Chen Y, Sun J, Hu D, Zhang J, Xu Y, Feng
H, Chen Z, Luo Y, Lou Y and Wu H: Predictive value of pretreatment
lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in
the survival of nasopharyngeal carcinoma patients. Cancer Manag
Res. 13:8767–8779. 2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ou D, Wang X, Wu M, Xue F, Li Y, Hu C and
He X: Prognostic value of post-radiotherapy
neutrophil-to-lymphocyte ratio in locally advanced nasopharyngeal
carcinoma. Strahlenther Onkol. 196:252–261. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chiang CL, Guo Q, Ng WT, Lin S, Ma TSW, Xu
Z, Xiao Y, Li J, Lu T, Choi HCW, et al: Prognostic factors for
overall survival in nasopharyngeal cancer and implication for TNM
staging by UICC: A systematic review of the literature. Front
Oncol. 11(703901)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Peng WS, Xing X, Li YJ, Ding JH, Mo M, Xu
TT, Zhou X and Hu CS: Prognostic nomograms for nasopharyngeal
carcinoma with nodal features and potential indication for N
staging system: Validation and comparison of seven N stage schemes.
Oral Oncol. 144(106438)2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhong J, Chen H, Chen X, Ma N, Huang Y,
Lin S, Pan J, Chen Y, Lu T, Xiao Y, et al: Identifying adverse
nodal features associated with poor prognosis in stage IB
nasopharyngeal carcinoma patients based on the 9th AJCC/UICC
staging system: Implications for treatment intensification.
Radiother Oncol. 205(110747)2025.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Guo LF, Dai YQ, Yu YF and Wu SG:
Gender-specific survival of nasopharyngeal carcinoma in endemic and
non-endemic areas based on the US SEER database and a Chinese
single-institutional registry. Clin Epidemiol. 16:769–782.
2024.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Peduzzi P, Concato J, Feinstein AR and
Holford TR: Importance of the number of events per independent
variable in proportional hazards regression analysis II. Accuracy
and precision of regression estimates. J Clin Epidemiol.
48:1503–1510. 1995.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Altman DG, Lausen B, Sauerbrei W and
Schumacher M: Dangers of using ‘optimal’ cutpoints in the
evaluation of prognostic factors. J Natl Cancer Inst. 86:829–835.
1994.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Steyerberg EW, Uno H, Ioannidis JPA, van
Calster B, Pencina MJ, Moons KG, Kattan MW and Harrell FE Jr: Poor
performance of clinical prediction models: The harm of commonly
applied methods. J Clin Epidemiol. 98:133–143. 2018.PubMed/NCBI View Article : Google Scholar
|
